Home › Funds › Trails Edge Capital Partners, LP › VTVT

Trails Edge Capital Partners, LP position in VTVT

VTV THERAPEUTICS INC · Health Care

Trails Edge Capital Partners, LP reported holding 85,192 shares of VTVT (VTV THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$3.2M, representing 0.51% of its reported portfolio and ranking #34 among its reported holdings. Trails Edge Capital Partners, LP has disclosed VTVT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)85.19K sh
Reported value held$3.21M
Portfolio Weight0.51%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Trails Edge Capital Partners, LP's VTVT position evolved

Trails Edge Capital Partners, LP first disclosed a stake in VTVT in Q4 2025 at 231,000 shares (US$9.2M). Across 3 filings, Trails Edge Capital Partners, LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 85,192 shares valued at US$3.2M — a reduction of -54,386 shares quarter over quarter.. Notable position changes include a 40% trim in Q1 2026 (shares fell 5% over the following quarter), a 39% trim in Q2 2026 (shares fell 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 231.00K $9.24M New
Q1 2026 139.58K $5.54M Reduce
Q2 2026 85.19K $3.21M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VTVT and 13F data

VTVT (VTV THERAPEUTICS INC) is a Health Care company. 43 other funds we track also report a position in VTVT — the largest reported positions include Samsara BioCapital, LLC (US$11.2M), Aisling Capital Management LP (US$1.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VTVT

All VTVT fund holders →

FAQ

How long has Trails Edge Capital Partners, LP held VTVT?

Trails Edge Capital Partners, LP has disclosed VTVT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Trails Edge Capital Partners, LP's current position in VTVT?

As of Q2 2026, Trails Edge Capital Partners, LP holds 85.19K shares of VTVT (VTV THERAPEUTICS INC), valued at $3.21M, representing 0.51% of its reported portfolio and ranking #34.

Has Trails Edge Capital Partners, LP been buying or selling VTVT?

In the latest 13F filing (Q2 2026), Trails Edge Capital Partners, LP reduced its position in VTVT.

Which other funds hold VTVT?

Other major institutional holders of VTVT include Samsara BioCapital, LLC, Aisling Capital Management LP, among 43 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.